4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001193125-26-294871
Options or other derivatives
- Director acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Mulroy Michael H. · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-01 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +125,000 | 125,000 | D |
Loading xslF345X06/ownership.xml…